Hostname: page-component-cb9f654ff-r5d9c Total loading time: 0 Render date: 2025-08-11T11:59:29.116Z Has data issue: false hasContentIssue false
  • English
  • Français

The Association of Diabetes and Glucose Control With Surgical-Site Infections Among Cardiothoracic Surgery Patients

Published online by Cambridge University Press:  02 January 2015

Robert Latham ,
Ava D. Lancaster ,
Janet F. Covington ,
John S. Pirolo  and
Clarence S. Thomas Jr
Robert Latham*
Affiliation:
Department of Medicine, Vanderbilt University, Nashville, Tennessee Hospital Epidemiology, Saint Thomas Hospital, Nashville, Tennessee
Ava D. Lancaster
Affiliation:
Hospital Epidemiology, Saint Thomas Hospital, Nashville, Tennessee
Janet F. Covington
Affiliation:
Hospital Epidemiology, Saint Thomas Hospital, Nashville, Tennessee
John S. Pirolo
Affiliation:
Cardiovascular Surgical Associates, Saint Thomas Heart Institute, Saint Thomas Hospital, Nashville, Tennessee
Clarence S. Thomas Jr
Affiliation:
Cardiovascular Surgical Associates, Saint Thomas Heart Institute, Saint Thomas Hospital, Nashville, Tennessee
*
PO Box 380, Saint Thomas Hospital, Nashville, TN 37202
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the importance of diabetes, diabetes control, hyperglycemia, and previously undiagnosed diabetes in the development of surgical-site infections (SSIs) among cardiothoracic surgery patients.

Setting:

A 540-bed tertiary-care university-affiliated hospital.

Design:

Prospective cohort and case-control studies.

Patients:

All patients having cardiothoracic surgery between November 1998 and September 1999 were eligible for participation. One thousand patients had preoperative hemoglobin Ale determinations. Seventy-four patients with SSIs were identified.

Results:

Diabetes (odd ratio [OR], 2.76; P<.001) and postoperative hyperglycemia (OR, 2.02; P=.007) were independently associated with development of SSIs. Among known diabetics, elevated hemoglobin Ale values were not associated with a statistically significantly increased risk of infection; the mean Ale value was 8.44% among those with infections compared with 7.80% for those without (P=.09). Forty-two (6%) of 700 patients without prior diabetes history had evidence of undiagnosed diabetes; their infection rate was comparable to that of known diabetics (3/42 [796] vs 17/300 [6%]; P=.72). An additional 30% of nondiabetics had elevated hemoglobin Ale determinations or perioperative hyperglycemia.

Conclusions:

Postoperative hyperglycemia and previously undiagnosed diabetes are associated with development of SSIs among cardiothoracic surgery patients. Screening for diabetes and hyperglycemia among patients having cardiothoracic surgery may be warranted to prevent postoperative and chronic complications of this metabolic abnormality.

Information

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 10 , October 2001 , pp. 607 - 612
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Zacharias, A, Habib, RH. Factors predisposing to median sternotomy complications: deep vs superficial infection. Chest 1996;110:1173–1178.CrossRefGoogle ScholarPubMed
2. Vuorisalo, S, Haukipuro, K, Pokela, R, Syrjala, H. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1998;19:240–247.CrossRefGoogle ScholarPubMed
3. Slaughter, MS, Olson, MM, Lee, JT Jr, Ward, HB. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg 1993;56:1063–1068.Google Scholar
4. Nagachinta, T, Stephens, M, Reitz, B, Polk, B. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 1987;156:967–973.Google Scholar
5. Lillenfeld, D, Engin, M, Vlahov, D, Tenney, J, McLaughlin, J. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 1988;16:3–6.Google Scholar
6. Borger, MA, Rao, V, Weisel, RD, Ivanov, J, Cohen, G, Scully, HE, et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 1998;65:1050–1056.CrossRefGoogle ScholarPubMed
7. Baxter, J, Babineau, B, Apovian, C, et al. Perioperative glucose control predicts increased nosocomial infection in diabetics. Crit Care Med 1990;18(suppl):S207. Abstract.CrossRefGoogle Scholar
8. Pomposelli, JJ, Baxter, JK 3rd, Babineau, TJ, Pomfret, EA, Driscoll, DF, Forse, RA, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77–81.CrossRefGoogle ScholarPubMed
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetics on the development and progression of long-term complications in insulin-dependent diabetes melli-tus. N Engl J Med 1993;329:977–986.CrossRefGoogle Scholar
10. Harris, M, Flegal, KM, Cowie, CC, Eberhardt, MS, Goldstein, DE, Little, RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518–524.CrossRefGoogle ScholarPubMed
11. Levetan, C, Passo, M, Jasblonski, K, Kass, M, Ratner, R. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21:246–249.Google Scholar
12. Emori, TG, Culver, DH, Horan, TC, Jarvis, WR, White, JW, Olson, DR, et al. National Nosocomial Infections Surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19:19–35.Google Scholar
13. Horan, T, Gaynes, R, Martone, W, Jarvis, W, Emori, T. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.CrossRefGoogle ScholarPubMed
14. Abbott Laboratories. IMx System: Glycated Hemoglobin. Package insert. Abbott Park, IL: Abbott Laboratories; 1994.Google Scholar
15. Peters, A, Davidson, M, Schriger, D, Hasselblad, V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. JAMA 1996;276:1246–1252.Google Scholar
16. Schlesselman, JJ. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:203–206.Google Scholar
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21:S5–S19.CrossRefGoogle Scholar
18. Davidson, M, Schriger, D, Peters, A, Lorber, B. Relationship between fasting plasma glucose and glycosylate hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281:1203–1210.Google Scholar
19. Husband, DJ, Alberti, KG, Julian, DG. “Stress” hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet 1983;2:179–181.CrossRefGoogle ScholarPubMed
20. Gerstein, HC. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med 1997;14(suppl 3):S25–S31.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
21. McMahon, M, Bistrian, B. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1–9.CrossRefGoogle ScholarPubMed
22. Bagdade, JD, Stewart, M, Walters, E. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978;27:677–681.CrossRefGoogle ScholarPubMed
23. Mowat, A, Baum, J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971;284:621–627.Google Scholar
24. Delamaire, M, Maugendre, D, Moreno, M, LeGoff, M, Allannic, H, Genetet, B. Impaired leucocyte functions in diabetic patients. Diabet Med 1996;14:29–34.3.0.CO;2-V>CrossRefGoogle Scholar
25. Alecxiewicz, J, Kumar, D, Smogorzewski, M, Win, M, Massey, S. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995;123:919–924.Google Scholar
26. MacRury, SM, Gemmell, CG, Paterson, KR, MacCuish, AC. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 1989;42:1143–1147.Google Scholar
27. Nielson, CP, Hindson, DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38:1031–1035.CrossRefGoogle ScholarPubMed
28. Zerr, KJ, Furnary, AP, Grunkemeier, GL, Bookin, S, Kanhere, V, Starr, A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356–361.CrossRefGoogle ScholarPubMed
29. Furnary, A, Zerr, K, Grunkemeier, G, Starr, A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352–362.CrossRefGoogle ScholarPubMed
30. Krolewski, A, Laffel, L, Krolewski, B, Quin, M, Warram, J. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251–1255.CrossRefGoogle ScholarPubMed
31. Haffner, S. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. Diabetes Care 1999;2:C54–C56.Google Scholar
32. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 1999;22:S20–S23.Google Scholar
33. CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998;280:1757–1763.Google Scholar
34. Malmberg, K, Ryden, L, Efendic, S, Herlitz, J, Nicol, P, Waldenstrom, A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality a 1 year. J Am Coll Cardiol 1995;26:57–65.CrossRefGoogle Scholar
35. Malmberg, K, Ryden, L, Hamsten, A, Herlitz, J, Waldenstrom, A, Wendel, H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Eur Heart J 1996;17:1337–1344.CrossRefGoogle ScholarPubMed
36. Malmberg, K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314:1512–1515.CrossRefGoogle ScholarPubMed